期刊文献+

人干扰素调节因子3基因启动子的初步鉴定 被引量:1

Characterization of promoter of human interferon regulatory factor 3
原文传递
导出
摘要 目的克隆并鉴定人干扰素调节因子3(IRF3)基因启动子,为进一步研究其转录调控机制奠定基础。方法用BLAST分析软件进行序列比较和同源分析不同种系IRF3启动子序列,以人类基因组DNA为模板,通过PCR定向克隆和酶切亚克隆策略,构建了覆盖IRF3基因5’侧翼区转录起始位点上游1kb区域的一系列IRF3启动子虫荧光素酶报告基因重组体并瞬时转染宫颈癌HeLa细胞,用虫荧光素酶检测报告基因启动子的活性。结果在人、小鼠的IRF3推断的启动子区域进行同源比较发现,推断的E2F和GATA-1高度进化保守;启动子活性分析表明,IRF3启动子区域定位于主要转录起始位点区域前111~167bp的区域内。采用转录因子结合位点预测分析软件分析表明,该区域内存在E2F转录因子结合位点。结论-167~111bp区存在IRF3启动子的核心调控元件,转录因子E2F可能参与IRF3的转录调控。 Objective To clone and identify the promoter of human interferon regulatory factor 3 ( IRF3 ) and to further investigate its transcriptional regulation. Methods The promoter sequences of IRF3 from different species were analyzed by BLAST. Several overlapping genomic fragments from the 5'-flanking region of IRF3 gene have been then cloned into pGL3-Basic vector to construct IRF3 promoter reporters. Then transfection of HeLa cells with the promoter-driven luciferase constructs was performed to induce lucif- erase gene express and calculate luciferase activity. Results Homologous. sequence comparison in IRF3 promoter area among human and mouse showed that putative E2F and GATA-I sites were highly evolutionally conserved. Luciferase reporter assay indicated that IRF3 promoter region was mainly located in 111-167 bp region before the major transcriptional start site. Transcriptional factor binding analysis indicated that IRF3 promoter included putative transcriptional factor binding sites: E2F. Conclusion The luciferase assays re- vealed that the -( 167-111 ) bp region was the minimal promoter of the human IRF3 gene. These results sug- gested that transcriptional factors such as E2F might be involved in the transcriptional regulation of IRF3 gene.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第8期732-736,共5页 Chinese Journal of Microbiology and Immunology
基金 基金项目:国家自然科学基金(30570863,30872804) 江苏省“科教兴卫工程”医学重点人才项目(RC2007050) 江苏省自然科学基金(BK2007244)
关键词 干扰素调节因子3(IRF3) 虫荧光素酶活性检测 启动子鉴定 转录调控 Interferon regulatory factor 3 ( IRF3 ) Luciferase assays Promoter characterization Transcriptional regulation
  • 相关文献

参考文献11

  • 1Au WC, Moore PA, Lowther W, et al. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of inter- feron-induced genes. Proc Natl Acad Sci USA, 1995, 92(25) : 11657-11661.
  • 2Lin R, Mamane Y, Hiscott J. Structural and functional analysis of interferon regulatory factor 3 : localization of the transactivation and autoinhibitory domains. Mol Cell Biol, 1999, 19(4) : 2465- 2474.
  • 3Honda K, Taniguehi T. IRFs : master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol, 2006, 6(9) : 644-658.
  • 4Spiegel M, Pichlmair A, Martinez-Sobrido L, et al. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol, 2005, 79 (4) : 2079-2086.
  • 5Foy E, Li K, Wang C, et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science, 2003, 300(5622) : 1145-1148.
  • 6Dogusan Z, Garcta M, Flamez D, et al. Double-stranded RNA induces pancreatic beta cell apoptosis by activation of the TLR3 and IRF-3 pathways. Diabetes, 2008, 57(5) : 1236-1245.
  • 7Fuse K, Chan G, Liu Y, et al. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation, 2005, 112(15) : 2276-2285.
  • 8Chow EK, Castrillo A, Shahangian A, et al. A role for IRF3-dependent RXRa repression in hepatotoxicity associated with viral infections. J Exp Med, 2006, 203(12) : 2589-2602.
  • 9Kim TK, Lee JS, Oh SY, et al. Direct transcriptional activation of promyeloeytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells. Cancer Res, 2007, 67(23) : 11133-11140.
  • 10Reily MM, Pantoja C, Hu X, et al. The GRIP1 : IRk3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. EMBO J, 2006, 25( 1 ) : 108-117.

同被引文献1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部